I now have comprehensive information from both the medical textbooks and web sources. Let me compile a detailed, well-structured answer.
Iron Requirements During Pregnancy & NIPI / Anemia Mukt Bharat
PART 1: IRON DEMANDS DURING PREGNANCY
Why Pregnancy Sharply Increases Iron Needs
During pregnancy, the body undergoes profound physiological changes that make iron one of the most critically demanded micronutrients. Two major forces drive this:
- Expansion of maternal red cell mass - Plasma volume expands by ~50%, and red cell mass expands by ~450 mL, requiring ~450 mg of iron purely for new hemoglobin synthesis.
- Fetal demands - Iron is actively transported across the placenta to the fetus regardless of maternal iron stores. This unidirectional transport prioritizes the fetus, meaning the mother goes deficient first.
Total Iron Requirement in Pregnancy
According to Goodman & Gilman and Creasy & Resnik's Maternal-Fetal Medicine, the total iron requirement across pregnancy is approximately ~1000-1190 mg, broken down as follows:
| Component | Iron Required |
|---|
| Expansion of maternal red cell mass | ~450 mg |
| Fetal iron requirements and loading | ~270-300 mg |
| Placental iron requirement and storage | ~90 mg |
| Basal maternal iron loss | ~230 mg |
| Blood loss at delivery | ~150 mg |
| TOTAL | ~1190 mg |
Source: Goodman & Gilman's, Table 45-3 - Iron Requirements for Pregnancy
The notes simplify this to ~1000 mg by emphasizing the two major components (500 mg for maternal RBCs, 300 mg for the fetus).
Trimester-by-Trimester Daily Requirements
Iron requirements are not evenly distributed across pregnancy - they rise sharply as the pregnancy advances:
| Trimester | Daily Iron Need | Reason |
|---|
| 1st Trimester (T1) | ~0.8 mg/day | Minimal fetal demand; menstruation has stopped |
| 2nd Trimester (T2) | ~4-5 mg/day | Red cell mass expansion accelerates |
| 3rd Trimester (T3) | ~7.5 mg/day | Maximum fetal loading; peak RBC expansion |
| Average across pregnancy | ~4-6 mg/day | Used as the commonly quoted figure |
Why supplementation is mandatory: In mid-to-late pregnancy, the daily iron absorption requirement is ~80 µg/kg body weight - but even a good diet only provides ~18-36 µg/kg. The safety factor is only 0.22-0.45, meaning diet alone can meet less than half the requirement. The body cannot compensate through enhanced absorption alone. - Goodman & Gilman's, Table 45-4
Iron Absorption Physiology
- Only ~10% of dietary iron is absorbed under normal circumstances.
- This is why the daily supplementation dose is 40-60 mg elemental iron - even though the daily need is 4-7.5 mg, you must give ~10x that amount to actually absorb enough.
- Heme iron (from meat/blood) is absorbed much better (~25-30%) than non-heme iron (~3-8%).
- Ascorbic acid (Vitamin C) enhances non-heme iron absorption.
- Phytates, tannins (tea), calcium, and phosphates inhibit non-heme iron absorption.
- Absorption occurs primarily in the duodenum and upper jejunum via the DMT1 (divalent metal transporter) system.
Mechanism of Iron Transfer to Fetus
Iron crosses the placenta by active transport - it is not passive diffusion. Key points:
- Transferrin (the iron-carrying plasma protein) delivers iron to transferrin receptors on the placental syncytiotrophoblast.
- Iron is internalized, released, and re-exported across the placenta via ferroportin.
- This active system ensures the fetus gets iron even when maternal stores are depleted - the mother becomes iron-deficient before the fetus does.
- Iron stores in infants are set during the last trimester (fetal iron loading), which is why preterm babies are highly vulnerable to iron deficiency.
Consequences of Iron Deficiency in Pregnancy
| For Mother | For Fetus/Neonate |
|---|
| Iron deficiency anemia (IDA) - most common anemia in pregnancy | Preterm birth |
| Fatigue, reduced work capacity | Low birth weight |
| Increased infection risk | Impaired neurodevelopment |
| Increased maternal mortality (severe anemia) | Neonatal IDA |
| Postpartum hemorrhage risk | Poor cognitive outcomes |
PART 2: ANEMIA MUKT BHARAT (AMB) & INTENSIFIED NIPI
Background and Timeline
| Year | Programme |
|---|
| 1970 | National Nutritional Anemia Prophylaxis Programme (NNAPP) |
| 1991 | National Nutritional Anemia Control Programme |
| 2007 | 12 by 12 Initiative |
| 2013 | National Iron Plus Initiative (NIPI) - first launched |
| 2018 | Anemia Mukt Bharat (Intensified NIPI) - currently active |
The Anemia Mukt Bharat (AMB) is India's flagship programme to combat iron deficiency anemia, officially termed the Intensified National Iron Plus Initiative (I-NIPI). It was launched in 2018 under the Ministry of Health and Family Welfare, aligning with POSHAN Abhiyaan and the World Health Assembly target of 50% reduction in anemia among women of reproductive age by 2025.
Target: Reduce anemia prevalence by 3 percentage points per year among children, adolescents, and women of reproductive age (15-49 years).
Scale: Estimated to reach 450 million beneficiaries across India.
The Red IFA Tablet (Given in Pregnancy)
Each red-coloured IFA tablet contains:
- 60 mg of elemental iron (as ferrous sulphate)
- 500 mcg (0.5 mg) of folic acid - this is the RDA for pregnancy
Note: Your notes state 40-60 mg - the current AMB standard tablet contains 60 mg elemental iron for pregnant women.
Regimen: 1 tablet daily starting from the 4th month (2nd trimester) of pregnancy, continued throughout pregnancy and for 180 days postpartum (a minimum of 180 days total during pregnancy).
The 6 x 6 x 6 Strategy
This is the structural framework of AMB. It has three dimensions of 6:
Dimension 1: 6 BENEFICIARIES (Target Groups)
The programme takes a life-cycle approach, covering:
| # | Beneficiary Group | Age |
|---|
| 1 | Children (infants/toddlers) | 6-59 months |
| 2 | Children (school-age) | 5-9 years |
| 3 | Adolescent girls and boys | 10-19 years |
| 4 | Women of Reproductive Age (non-pregnant) | 15-49 years |
| 5 | Pregnant Women | - |
| 6 | Lactating Mothers | - |
Your notes mention "pregnant females and non-pregnant females of reproductive age" - the full programme actually covers all 6 groups including children and adolescents.
Dimension 2: 6 INTERVENTIONS
| # | Intervention | Details |
|---|
| 1 | Prophylactic IFA Supplementation | Age-specific iron + folic acid tablets/syrups (see below) |
| 2 | Deworming | Albendazole 400 mg - see below for timing |
| 3 | Behaviour Change Communication (BCC) | "Solid Body, Smart Mind" campaign - promoting IFA compliance, IYCF, diet diversity, cord clamping |
| 4 | Testing & Treatment | Digital haemoglobinometer for screening; point-of-care treatment; IV iron sucrose for moderate anaemia |
| 5 | Food Fortification | Mandatory IFA-fortified foods in all government-funded programmes (midday meals, ICDS, PDS) |
| 6 | Addressing Non-nutritional Causes | Malaria, haemoglobinopathies, fluorosis, infection |
Dimension 3: 6 INSTITUTIONAL MECHANISMS (Delivery Platforms)
The programme is delivered through 6 existing institutional channels:
- Anganwadi Centres (AWC/ICDS)
- Schools (through WIFS - Weekly Iron Folic Acid Supplementation)
- Primary Health Centres (PHC)
- Community Health Centres (CHC)
- Sub-centres/ANM (Auxiliary Nurse Midwife)
- Hospitals/Medical Colleges
IFA Supplementation by Age Group
| Beneficiary | Formulation | Dose | Frequency |
|---|
| 6-59 months | IFA syrup (blue) | 1 ml/day (20 mg Fe) | Daily |
| 5-9 years | Pink tablet (small) | 45 mg Fe + 400 mcg FA | Weekly |
| Adolescents 10-19 yrs | Blue tablet | 60 mg Fe + 500 mcg FA | Weekly (WIFS) |
| Women 15-49 yrs (non-pregnant) | Blue tablet | 60 mg Fe + 500 mcg FA | Weekly |
| Pregnant women | Red tablet | 60 mg Fe + 500 mcg FA | Daily |
| Lactating mothers | Red tablet | 60 mg Fe + 500 mcg FA | Daily (180 days post-delivery) |
Intervention Details
1. Digital Haemoglobinometer (Screening)
- Used for point-of-care Hb testing, especially at ANM level, schools, and anganwadis.
- Enables rapid, accurate field diagnosis without a laboratory.
- Grading of anemia in pregnancy:
- Normal: Hb ≥ 11 g/dL
- Mild: 10-10.9 g/dL
- Moderate: 7-9.9 g/dL → IV iron sucrose
- Severe: < 7 g/dL → blood transfusion
2. IFA Tablets (Prevention + Treatment)
- The backbone of the programme.
- Must be taken with water (not milk or tea, which inhibit absorption).
- Best taken at night or between meals to reduce GI side effects (nausea, constipation).
3. Deworming with Albendazole
Worm infestations (especially hookworm) cause significant intestinal blood loss, worsening iron deficiency. Deworming is therefore integral to the programme:
| Group | Dose | Timing |
|---|
| Pregnant women | Albendazole 400 mg single dose | 2nd trimester only (14th week onwards - safe after organogenesis) |
| Non-pregnant women | Albendazole 400 mg | Bi-annually (every 6 months) |
| Children | Albendazole 400 mg | Bi-annually |
Important: Albendazole is contraindicated in the 1st trimester (teratogenic risk during organogenesis). It is given only from the 2nd trimester in pregnancy.
4. Delayed Cord Clamping
- AMB recommends delayed cord clamping for at least 3 minutes (some guidelines say 60 seconds minimum for term infants) after delivery.
- Allows placental blood to transfuse back to the neonate: increases neonatal blood volume by ~30% and iron stores by ~50 mg.
- Reduces risk of neonatal iron deficiency anemia, especially important in resource-limited settings.
- Evidence from Creasy & Resnik's supports this practice, noting it improves hematocrit at 2 hours of age without adverse effects on resuscitation.
5. Food Fortification
- Mandatory fortification of staple foods distributed through government platforms: PDS rice/wheat, midday meal grains, ICDS complementary foods.
- Targets the population that cannot rely on supplementation compliance alone.
- Reduces the baseline iron deficiency burden in the general population.
6. Addressing Other Causes of Anemia
Anemia in India is not purely due to iron deficiency. The programme explicitly targets:
- Malaria - causes hemolysis; treated with antimalarials
- Haemoglobinopathies - sickle cell disease, thalassemia (endemic in tribal belts)
- Fluorosis - chronic fluoride toxicity causes anemia in endemic areas
- Vitamin B12/folate deficiency - causes megaloblastic anemia
- Infection and inflammation - causes anemia of chronic disease
Why Folic Acid is Combined with Iron
Folic acid (500 mcg in the red tablet) is included because:
- Neural tube defects (NTDs) - folic acid prevents spina bifida and anencephaly when taken periconceptionally and in early pregnancy.
- Megaloblastic anemia - folate deficiency in pregnancy causes macrocytic anemia; combined with iron deficiency creates a "dimorphic anemia."
- 500 mcg is the RDA during pregnancy (higher than the normal adult RDA of 400 mcg).
- Iron alone cannot treat megaloblastic anemia; folate alone cannot treat IDA - the combination covers both.
Key Numbers to Remember (Exam Quick Recap)
| Parameter | Value |
|---|
| Total iron requirement in pregnancy | ~1000-1190 mg |
| Iron for maternal RBC expansion | ~450-500 mg |
| Iron for fetus | ~270-300 mg |
| 1st trimester daily need | 0.8 mg/day |
| 3rd trimester daily need | 7.5 mg/day |
| Average daily need | 4-6 mg/day |
| Dietary iron absorbed | Only 10% |
| Supplementation daily dose | 40-60 mg elemental iron |
| Red IFA tablet composition | 60 mg Fe + 500 mcg FA |
| AMB launch year | 2018 |
| Target reduction in anemia | 3% per year |
| Albendazole in pregnancy | 400 mg, 2nd trimester only |
| Delayed cord clamping duration | 3 minutes (AMB guideline) |
| Colour of IFA tablet for pregnant women | Red |
| Colour for adolescents/WRA | Blue |
| Colour for school children | Pink |
Sources:
- Goodman & Gilman's Pharmacological Basis of Therapeutics, Tables 45-3 and 45-4 (Iron requirements in pregnancy)
- Park's Textbook of Preventive and Social Medicine - Anaemia Mukt Bharat Strategy and NIPI
- Creasy & Resnik's Maternal-Fetal Medicine - Iron kinetics in pregnancy
- AMB Official PIB Release
- AMB Training Modules, Ministry of Health